NEO – neogenomics, inc. (US:NASDAQ)

News

NeoGenomics to Participate in the Piper Sandler 36th Annual Healthcare Conference
NeoGenomics, Inc. (NASDAQ: NEO) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $19.00 price target on the stock.
NeoGenomics Third Quarter 2024 Earnings: EPS Beats Expectations [Yahoo! Finance]
NeoGenomics Inc (NEO) Q3 2024 Earnings Call Highlights: Record Revenue Growth and Strategic ... [Yahoo! Finance]
NeoGenomics Reports Third Quarter 2024 Results
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com